[144] BeOne Medicines Ltd. SEC Filing

Rhea-AI Filing Summary

ONC: A shareholder filed a Form 144 notice to sell up to 6,009 shares of common stock, with an aggregate market value of $2,286,659.45. The filer lists Morgan Stanley Smith Barney LLC as broker, an approximate sale date of November 13, 2025, and the NASDAQ as the exchange.

The notice shows shares were acquired via restricted stock vesting under a registered plan on multiple dates. The table also reports 109,663,273 shares outstanding. Recent activity by the same seller over the past three months includes sales of 49,858 shares on August 13, 2025 for $15,162,320.35, 39,936 shares on August 14, 2025 for $12,180,813.46, and 10,000 shares on November 12, 2025 for $3,560,160.50.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6009	2286659.45	109663273	11/13/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/17/2024	Restricted stock vesting under a registered plan	Issuer			1461	06/17/2024	Not Applicable
Common	03/12/2025	Restricted stock vesting under a registered plan	Issuer			66	03/12/2025	Not Applicable
Common	06/05/2025	Restricted stock vesting under a registered plan	Issuer			186	06/05/2025	Not Applicable
Common	06/22/2024	Restricted stock vesting under a registered plan	Issuer			2154	06/22/2024	Not Applicable
Common	06/16/2024	Restricted stock vesting under a registered plan	Issuer			873	06/16/2024	Not Applicable
Common	06/15/2024	Restricted stock vesting under a registered plan	Issuer			1194	06/15/2024	Not Applicable
Common	09/11/2024	Restricted stock vesting under a registered plan	Issuer			75	09/11/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Xiaobin Wu 94 Solaris Avenue, Camana Bay Grand Cayman E9 KY1 1108	Common	11/12/2025	10000	3560160.50
Xiaobin WU 94 Solaris Avenue, Camana Bay Grand Cayman E9 KY1 1108	Common	08/14/2025	39936	12180813.46
Xiaobin Wu 94 Solaris Avenue, Camana Bay Grand Cayman E9 KY1 1108	Common	08/13/2025	49858	15162320.35

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does ONC’s latest Form 144 filing disclose?

A shareholder plans to sell up to 6,009 common shares with an aggregate market value of $2,286,659.45 on NASDAQ around November 13, 2025.

Who is the broker listed in ONC’s Form 144?

The filing lists Morgan Stanley Smith Barney LLC as the broker.

How many ONC shares are outstanding according to the notice?

The table reports 109,663,273 shares outstanding.

How were the ONC shares to be sold acquired?

They were acquired through restricted stock vesting under a registered plan on multiple dates.

What recent ONC share sales by the same seller are disclosed?

Past three months include 49,858 shares on Aug 13, 2025 for $15,162,320.35, 39,936 shares on Aug 14, 2025 for $12,180,813.46, and 10,000 shares on Nov 12, 2025 for $3,560,160.50.

Which exchange is named for the planned ONC sale?

The filing names the NASDAQ.